resources

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

120.40+5.7 (+4.97%)

14 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Aspira Pathlab & Diagnostics Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Sept	Jun Dec	Mar	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Aspira Pathlab & Diagnostics Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under reg 74(5) of SEBI (DP) regulation, 2018 for the quarter ended September 30, 2026.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Oct 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201128 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
AGM25 Sept 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report
AGM25 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached summary of proceeding /outcome of the 53rd Annual General Meeting of the Company held on Friday,25th September,2026
Closure of Trading Window23 Sept 2026
Closure of Trading Window
Closure of Trading Window for quarter ended September 30,2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201116 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
General12 Sept 2026
Announcement Under Regulation 30_Constitution Of Right Issue Committee
Enclosed herewith Constitution of Right Issue Committee for proposed right issue
Raising of Funds12 Sept 2026
Announcement under Regulation 30 (LODR)-Raising of Funds
Intimation under Regulation 30 (LODR) -Raising of Funds
Outcome of Board Meeting12 Sept 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th September 2026
The Board of Directors of the Company in its meeting held on 12th September, 2026 have considered and approved the following matters; 1) To raise Fund for an amount not exceeding Rs. 65,00,00,000/- ....
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Board Meeting7 Sept 2026
Board Meeting Intimation for To Consider Approve The Proposal For Raising Funds Through The Issuance Of Equity Shares, Warrants Convertible Into Equity Shares, Or Other Permitted Instruments By Way Of Preferential Issue, Private Placement, Rights Issue Or Any Combination.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/09/2026 ,inter alia, to consider and approve To consider approve ....
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20115 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20113 Sept 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
General1 Sept 2026
Letters Dispatched To Non-Email Shareholders
Pursuant to Regulation 36 (1)(b) of SEBI (LODR)2015, The Company has dispatched letter containing weblink of Annual Report for Financial year 2025-26
Newspaper Publication1 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication Post Dispatch of 53rd AGM Notice & Annual Report for the Financial Year 2025-26
Reg. 34 (1) Annual Report31 Aug 2026
Reg. 34 (1) Annual Report.
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of the Notice of ....
AGM31 Aug 2026
Notice Convening 53Rd Annual General Meeting To Be Held On Friday, September 25, 2026 At 02.00 P.M Through Video Conferencing Mode.
Intimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-26
Book Closure31 Aug 2026
Intimation Of Book Closure Date, Notice Of The 53Rd Annual General Meeting And E-Voting Date
With reference to subject matter please find the attached Documents
Newspaper Publication28 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Information Regarding 53rd (Fifty -Three) Annual General Meeting of the company

Frequently Asked Questions

Where can I download the annual report of Aspira Pathlab & Diagnostics Ltd.?

Annual reports of Aspira Pathlab & Diagnostics Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Aspira Pathlab & Diagnostics Ltd.?

Quarterly earnings results and presentations of Aspira Pathlab & Diagnostics Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Aspira Pathlab & Diagnostics Ltd. publish earnings call transcripts?

Earnings call transcripts of Aspira Pathlab & Diagnostics Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Aspira Pathlab & Diagnostics Ltd.?

Investor presentations and annual day presentations of Aspira Pathlab & Diagnostics Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Aspira Pathlab & Diagnostics Ltd.?

Corporate announcements and regulatory filings of Aspira Pathlab & Diagnostics Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Aspira Pathlab & Diagnostics Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Aspira Pathlab & Diagnostics Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Aspira Pathlab & Diagnostics Ltd.?

The ISIN (International Securities Identification Number) of Aspira Pathlab & Diagnostics Ltd. is INE500C01017. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Aspira Pathlab & Diagnostics Ltd. listed?

Aspira Pathlab & Diagnostics Ltd. is listed on NSE and BSE. The NSE symbol is ASPIRA and the BSE code is -.

Where can I find the shareholding pattern of Aspira Pathlab & Diagnostics Ltd.?

The quarterly shareholding pattern of Aspira Pathlab & Diagnostics Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Aspira Pathlab & Diagnostics Ltd. on Sharpely?

Share price data for Aspira Pathlab & Diagnostics Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.